Rising prevalence of Epilepsy, Parkinson’s disease to boost the Stereotactic Systems Market growth

 

Stereotactic Systems Market By Type (Gamma Knife, Linear Accelerator, CyberKnife, Proton Beam Therapy), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Outlook, Size, Share, and Opportunity Analysis, 2023 – 2030

The global Stereotactic Systems Market is estimated to be valued at US$ XX million in XXX and is expected to exhibit a CAGR of XX% over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The word stereotactic indicates to the usage of 3D coordinate method coupled with an imagery method, such as computed tomography, scanning or magnetic resonance imaging, to specifically find targets profound within the intellect or the cerebrum.

Competitive Landscape:

Key players involved in the growth of the global Stereotactic Systems Market are Varian Medical Systems, Siemens Ag Accuray Incorporated Elekta AB and IBA.

Market Key Drivers:

Rising prevalence of Epilepsy, Parkinson’s disease is expected to augment the growth of the global stereotactic systems market. For instance, as per WHO, around 9.4 Million people globally suffer from Parkinson’s disease.

The rise in minimally invasive surgery is projected to boost the growth of global stereotactic systems market. For instance, as per the facts and figures, minimally invasive spine operation’s success rate is above 90%.

Covid-19 Impact Analysis:

The Covid-19 outbreak had adversely affected the growth of global stereotactic systems market. The surge of Covid-19 cases has led to the restriction on hospital visits and delay in other medical procedures apart from Covid-19 led to the declining. The rising focus of physicians towards pandemic cases also impeded the market growth.

Key Takeaways:

The global stereotactic systems market is expected to exhibit a CAGR of XX % during the forecast period due to rising regulatory initiatives. For instance, Plan Cancer 2014 - 2019 mainly aims on strengthening efforts to stop inequity in approval & accessibility of transmission and enhanced efficacy of events to decrease avoidable mortalities & serious treatments linked with deferred care.

Among region North America, Asia Pacific and Europe are anticipated to witness robust growth in the global stereotactic systems market due to rising prevalence of cancer, rising regulatory initiatives, increasing healthcare expenditure. For instance, as per WCRF, 1.9 million people were living with cancer and 609,360 cancer mortalities occurred in 2022.